Recent news
            Kaneka Eurogentec completes commercial mRNA..
Company
            Company
            
    
    Products & Services
            Exhibitions
        18-19 November, 2025
        11-13 November 2025
We produce plasmid DNA, recombinant proteins and Ab fragments up to kg scale for clinical and commercial human uses.
batch
We produce large scale mRNA in our GMP facilities.
We optimized our IVT process to synthesize and purify 50g of material in one batch.
This quantity is equivalent to 100,000’s to millions of doses of mRNA, potentially sufficient for late clinical and commercial uses.
Learn moreWe are pleased to assist you!
Quality management is fundamental for Eurogentec and is implemented by all personnel in their daily activities.